0 items USD 0.00Search
- Did you mean
- psoriasis arthrex
Your search for "Psoriatic arthritis" gave back 1190 results.
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Musculoskeletal Disorders Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Etanercept market size was valued at US$ million in 2023. With growing demand in downstream market, the Etanercept is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis,...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Musculoskeletal Disorders Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
